Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHA:600721)
China · Delayed Price · Currency is CNY 8.32
0.00 (0.00%)
Aug 1, 2025, 3:00 PM CST
Acelyrin Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 41.54 | 41.48 | 12.97 | -34.76 | 59.83 | -319.77 | Upgrade |
Depreciation & Amortization | 17.91 | 17.91 | 23.15 | 26.16 | 25.14 | 30.19 | Upgrade |
Other Amortization | 2.48 | 2.48 | 1.89 | 2 | 2 | 1.67 | Upgrade |
Loss (Gain) From Sale of Assets | -0.09 | -0.09 | -0.01 | -0 | -0 | -0.55 | Upgrade |
Asset Writedown & Restructuring Costs | 0.22 | 0.22 | -0.31 | -0.71 | -2.4 | 136.54 | Upgrade |
Loss (Gain) From Sale of Investments | -3.5 | -3.5 | -1.25 | 0.77 | 2.09 | -1.86 | Upgrade |
Provision & Write-off of Bad Debts | 27.95 | 27.95 | 16.46 | 16.53 | 8.72 | 1.53 | Upgrade |
Other Operating Activities | -0.41 | 32.02 | 37.17 | 43.07 | 11.44 | 26.18 | Upgrade |
Change in Accounts Receivable | -1.01 | -1.01 | -34.26 | -49.84 | 7.01 | -76.51 | Upgrade |
Change in Inventory | -7.49 | -7.49 | 4.21 | 2.5 | -16.72 | 41.32 | Upgrade |
Change in Accounts Payable | -13.08 | -13.08 | -4.05 | 37.01 | -67.97 | 135.43 | Upgrade |
Change in Other Net Operating Assets | -1.08 | -1.08 | 3.25 | 7.99 | 2.4 | -1.9 | Upgrade |
Operating Cash Flow | 47.92 | 80.29 | 62.08 | 53.18 | 34.72 | -23.28 | Upgrade |
Operating Cash Flow Growth | -45.88% | 29.33% | 16.74% | 53.15% | - | - | Upgrade |
Capital Expenditures | -22.07 | -24.61 | -17.24 | -2.41 | -6.04 | -3.77 | Upgrade |
Sale of Property, Plant & Equipment | 0.03 | 0.07 | 0.02 | 0.02 | 0 | 0.25 | Upgrade |
Cash Acquisitions | - | - | - | -4.9 | - | - | Upgrade |
Investment in Securities | -52.97 | - | - | -4 | 6 | 35.17 | Upgrade |
Other Investing Activities | 2.47 | 2.47 | 1.57 | 0.73 | 0.33 | 1.97 | Upgrade |
Investing Cash Flow | -72.54 | -22.08 | -15.65 | -10.56 | 0.3 | 33.63 | Upgrade |
Short-Term Debt Issued | - | - | - | - | 6.29 | - | Upgrade |
Total Debt Issued | - | - | - | - | 6.29 | - | Upgrade |
Short-Term Debt Repaid | - | - | - | -6.29 | - | -20 | Upgrade |
Total Debt Repaid | - | - | - | -6.29 | - | -20 | Upgrade |
Net Debt Issued (Repaid) | - | - | - | -6.29 | 6.29 | -20 | Upgrade |
Issuance of Common Stock | 11.54 | 11.77 | 19.91 | 12.64 | - | - | Upgrade |
Common Dividends Paid | - | - | - | -0.12 | -0.04 | -0.75 | Upgrade |
Other Financing Activities | - | - | - | - | - | 4.9 | Upgrade |
Financing Cash Flow | 11.54 | 11.77 | 19.91 | 6.23 | 6.25 | -15.85 | Upgrade |
Net Cash Flow | -13.08 | 69.98 | 66.34 | 48.85 | 41.27 | -5.51 | Upgrade |
Free Cash Flow | 25.84 | 55.68 | 44.84 | 50.77 | 28.68 | -27.05 | Upgrade |
Free Cash Flow Growth | -59.09% | 24.18% | -11.68% | 77.01% | - | - | Upgrade |
Free Cash Flow Margin | 6.60% | 14.44% | 12.14% | 14.51% | 10.20% | -32.00% | Upgrade |
Free Cash Flow Per Share | 0.07 | 0.15 | 0.12 | 0.14 | 0.08 | -0.07 | Upgrade |
Cash Income Tax Paid | 13.98 | 14.12 | 11.79 | 5.07 | 8.42 | 11.89 | Upgrade |
Levered Free Cash Flow | 39.92 | 66.32 | 46.43 | 65.6 | -24.76 | 65.8 | Upgrade |
Unlevered Free Cash Flow | 39.92 | 66.32 | 46.43 | 65.67 | -24.73 | 66.27 | Upgrade |
Change in Net Working Capital | -22.74 | -52.5 | -26.54 | -52.38 | 57.01 | -175.78 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.